Assembly Biosciences (ASMB) EBIT Margin Growth (1y) (2018 - 2026)
Assembly Biosciences (ASMB) EBIT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Assembly Biosciences | 431.63 Mn | 205.03 Mn | - | -3,290.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,290.00 |
| Dec 31, 2025 | 20,337.00 |
| Sep 30, 2025 | 5,919.00 |
| Jun 30, 2025 | 2,777.00 |
| Mar 31, 2025 | 7,992.00 |
| Dec 31, 2024 | 1,847.00 |
| Sep 30, 2021 | -29,019.00 |
| Dec 31, 2020 | -322,104.00 |
| Sep 30, 2020 | 60,273.00 |
| Jun 30, 2020 | 65,632.00 |
| Mar 31, 2020 | 5,076.00 |
| Dec 31, 2019 | 10,302.00 |
| Sep 30, 2019 | -8,763.00 |
| Jun 30, 2019 | 20,458.00 |
| Mar 31, 2019 | -26,171.00 |
| Dec 31, 2018 | -33,431.00 |
| Sep 30, 2018 | -5,866.00 |
| Jun 30, 2018 | -26,906.00 |
| Mar 31, 2018 | 156,887.00 |